Other languages ZIVO Bioscience, Inc.

Equities

ZIVO

US98978N3098

Market Closed - OTC Markets Other stock markets 01:24:41 2024-04-29 pm EDT			5-day change	1st Jan Change
6.55 ^USD	-19.14%		-18.12%	+445.83%

Mar. 15	ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 07	ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	Feb. 07
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	Jan. 23
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing	23-10-30
Zivo Says Trial Results Confirm Efficacy of Non-Antibiotic Product Candidate for Treating Coccidiosis in Broiler Chickens	23-09-19
Trial Results Confirm Efficacy of ZIVO Bioscience?s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-09-19
ZIVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Zivo Bioscience, Inc. Commences Sales of Its Proprietary Algal Biomass as Human Food	23-07-26
Zivo Biosciences to Raise $4 Million From Registered Direct Offering, Concurrent Private Placement; Shares Drop	23-06-30
Zivo Bioscience, Inc. Announces its GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as Human Food Ingredient	23-05-30
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Sector Update: Health Care Stocks Advance Premarket Thursday	23-04-06
Sector Update: Health Care	23-04-06
Top Premarket Decliners	23-04-06
Zivo Bioscience Obtains $1 Million Bridge Financing	23-04-05
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14
ZIVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt	23-03-13
Top Premarket Decliners	23-02-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ZIVO Bioscience, Inc.

Equities

ZIVO

US98978N3098

Other languages

Filters